These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6376485)

  • 1. Side effects of isocarboxazid.
    Zisook S
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):53-8. PubMed ID: 6376485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing treatment response to the monoamine oxidase inhibitor isocarboxazid.
    Giller E; Bialos D; Harkness L; Riddle M
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):44-8. PubMed ID: 6376484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of isocarboxazid on blood pressure and pulse.
    Davidson J; Turnbull CD
    J Clin Psychopharmacol; 1986 Jun; 6(3):139-43. PubMed ID: 3519694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The importance of dose in isocarboxazid therapy.
    Davidson J; Turnbull C
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):49-52. PubMed ID: 6735995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-blind comparative trials of fluoxetine and doxepin in geriatric patients with major depressive disorder.
    Feighner JP; Cohn JB
    J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):20-5. PubMed ID: 3882676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methodologic approach to adverse events applied to bupropion clinical trials.
    Cato AE; Cook L; Starbuck R; Heatherington D
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):187-90. PubMed ID: 6406455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind, placebo-controlled trial of two doses of abecarnil for geriatric anxiety.
    Small GW; Bystritsky A
    J Clin Psychiatry; 1997; 58 Suppl 11():24-9. PubMed ID: 9363045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duloxetine for the treatment of major depressive disorder: safety and tolerability associated with dose escalation.
    Wohlreich MM; Mallinckrodt CH; Prakash A; Watkin JG; Carter WP
    Depress Anxiety; 2007; 24(1):41-52. PubMed ID: 16845641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerability and safety: essentials in antidepressant pharmacotherapy.
    Lader MH
    J Clin Psychiatry; 1996; 57 Suppl 2():39-44. PubMed ID: 8626362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoamine oxidase inhibitors in the treatment of atypical depression.
    Zisook S; Braff DL; Click MA
    J Clin Psychopharmacol; 1985 Jun; 5(3):131-7. PubMed ID: 3889078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind comparison of Org 3770, amitriptyline, and placebo in major depression.
    Bremner JD
    J Clin Psychiatry; 1995 Nov; 56(11):519-25. PubMed ID: 7592505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gepirone extended-release: new evidence for efficacy in the treatment of major depressive disorder.
    Feiger AD; Heiser JF; Shrivastava RK; Weiss KJ; Smith WT; Sitsen JM; Gibertini M
    J Clin Psychiatry; 2003 Mar; 64(3):243-9. PubMed ID: 12716264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An overview of side effects and long-term experience with nomifensine from United States clinical trials.
    Yakabow AL; Hardiman S; Nash RJ
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):96-101. PubMed ID: 6370985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind, placebo-controlled assessment of nortriptyline's side-effects during 3-year maintenance treatment in elderly patients with recurrent major depression.
    Marraccini RL; Reynolds CF; Houck PR; Miller MD; Frank E; Perel JM; Cornes C; Mazumdar S; Kupfer DJ
    Int J Geriatr Psychiatry; 1999 Dec; 14(12):1014-8. PubMed ID: 10607968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duloxetine versus escitalopram and placebo: an 8-month, double-blind trial in patients with major depressive disorder.
    Pigott TA; Prakash A; Arnold LM; Aaronson ST; Mallinckrodt CH; Wohlreich MM
    Curr Med Res Opin; 2007 Jun; 23(6):1303-18. PubMed ID: 17559729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Duloxetine for the treatment of stress urinary incontinence in women: an integrated analysis of safety.
    Hurley DJ; Turner CL; Yalcin I; Viktrup L; Baygani SK
    Eur J Obstet Gynecol Reprod Biol; 2006 Mar; 125(1):120-8. PubMed ID: 16188367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, double-blind, placebo-controlled, parallel-group study to assess the efficacy and safety of dual ACE/NEP inhibitor GW660511X in mild-to-moderate hypertensive patients.
    Johnson AG; Pearce GL; Danoff TM
    J Hum Hypertens; 2006 Jul; 20(7):496-503. PubMed ID: 16543907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of isocarboxazid in hypertensive patients.
    Drapkin A; Goldberger E
    J New Drugs; 1966; 6(4):237-42. PubMed ID: 5338656
    [No Abstract]   [Full Text] [Related]  

  • 19. Isocarboxazid. Efficacy and tolerance.
    Davidson J; Turnbull C
    J Affect Disord; 1983 May; 5(2):183-9. PubMed ID: 6222098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse reactions to triazolam, flurazepam, and placebo in controlled clinical trials.
    Greenblatt DJ; Shader RI; Divoll M; Harmatz JS
    J Clin Psychiatry; 1984 May; 45(5):192-5. PubMed ID: 6144670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.